Biosig Technologies Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.402
- Today's High:
- $0.46
- Open Price:
- $0.455
- 52W Low:
- $0.251
- 52W High:
- $1.65
- Prev. Close:
- $0.45
- Volume:
- 299530
Company Statistics
- Market Cap.:
- $88.91 million
- Book Value:
- 0.03
- Revenue TTM:
- $283000
- Operating Margin TTM:
- -9394.35%
- Gross Profit TTM:
- $242000
- Profit Margin:
- 0%
- Return on Assets TTM:
- -187.34%
- Return on Equity TTM:
- -461.04%
Company Profile
Biosig Technologies Inc had its IPO on 2014-10-30 under the ticker symbol BSGM.
The company operates in the Healthcare sector and Medical Devices industry. Biosig Technologies Inc has a staff strength of 47 employees.
Stock update
Shares of Biosig Technologies Inc opened at $0.46 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.4 - $0.46, and closed at $0.41.
This is a -9.98% slip from the previous day's closing price.
A total volume of 299,530 shares were traded at the close of the day’s session.
In the last one week, shares of Biosig Technologies Inc have slipped by -30.16%.
Biosig Technologies Inc's Key Ratios
Biosig Technologies Inc has a market cap of $88.91 million, indicating a price to book ratio of 12.1688 and a price to sales ratio of 136.2013.
In the last 12-months Biosig Technologies Inc’s revenue was $283000 with a gross profit of $242000 and an EBITDA of $-26264000. The EBITDA ratio measures Biosig Technologies Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Biosig Technologies Inc’s operating margin was -9394.35% while its return on assets stood at -187.34% with a return of equity of -461.04%.
In Q1, Biosig Technologies Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 37.5%.
Biosig Technologies Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.41 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Biosig Technologies Inc’s profitability.
Biosig Technologies Inc stock is trading at a EV to sales ratio of 139.7587 and a EV to EBITDA ratio of -0.7663. Its price to sales ratio in the trailing 12-months stood at 136.2013.
Biosig Technologies Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $5.20 million
- Total Liabilities
- $2.81 million
- Operating Cash Flow
- $-45000.00
- Capital Expenditure
- $45000
- Dividend Payout Ratio
- 0%
Biosig Technologies Inc ended 2024 with $5.20 million in total assets and $0 in total liabilities. Its intangible assets were valued at $5.20 million while shareholder equity stood at $2.08 million.
Biosig Technologies Inc ended 2024 with $0 in deferred long-term liabilities, $2.81 million in other current liabilities, 67000.00 in common stock, $-223306000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $1.41 million and cash and short-term investments were $1.51 million. The company’s total short-term debt was $321,000 while long-term debt stood at $0.
Biosig Technologies Inc’s total current assets stands at $2.15 million while long-term investments were $0 and short-term investments were $101000.00. Its net receivables were $17000.00 compared to accounts payable of $2.49 million and inventory worth $345000.00.
In 2024, Biosig Technologies Inc's operating cash flow was $-45000.00 while its capital expenditure stood at $45000.
Comparatively, Biosig Technologies Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.41
- 52-Week High
- $1.65
- 52-Week Low
- $0.251
- Analyst Target Price
- $4.42
Biosig Technologies Inc stock is currently trading at $0.41 per share. It touched a 52-week high of $1.65 and a 52-week low of $1.65. Analysts tracking the stock have a 12-month average target price of $4.42.
Its 50-day moving average was $0.81 and 200-day moving average was $0.96 The short ratio stood at 7.68 indicating a short percent outstanding of 0%.
Around 1816.9% of the company’s stock are held by insiders while 806.4% are held by institutions.
Frequently Asked Questions About Biosig Technologies Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.